Skip to main content
. Author manuscript; available in PMC: 2024 Sep 22.
Published in final edited form as: J Nat Prod. 2023 Aug 29;86(9):2102–2110. doi: 10.1021/acs.jnatprod.3c00186

Figure 4.

Figure 4.

(A) Western blots and (B) densiometric analysis show an increase in cleaved PARP in eupenifeldin-treated OVCAR3 cells (72 h) but not OVCAR5 or OVCAR8 (48 h). Data represents mean ± SEM and three biological replicates. Data were quantified using ImageJ of cleaved PARP normalized to β-actin, and data points generated using one-way ANOVA with Dunnett’s multiple comparison test were used to produce P-values. (*P < 0.05).